EAM
Eventide Asset Management’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.6M | Buy |
848,141
+377,911
| +80% | +$12.3M | 0.48% | 76 |
|
|
2025
Q1 | $17.8M | Buy |
470,230
+86,776
| +23% | +$3.29M | 0.35% | 92 |
|
|
2024
Q4 | $31.4M | Hold |
383,454
| – | – | 0.57% | 58 |
|
|
2024
Q3 | $43.8M | Sell |
383,454
-355,699
| -48% | -$40.6M | 0.76% | 45 |
|
|
2024
Q2 | $55.8M | Buy |
739,153
+81,947
| +12% | +$6.19M | 0.96% | 33 |
|
|
2024
Q1 | $44.9M | Buy |
657,206
+50,000
| +8% | +$3.42M | 0.7% | 53 |
|
|
2023
Q4 | $38.1M | Buy |
607,206
+214,206
| +55% | +$13.5M | 0.62% | 55 |
|
|
2023
Q3 | $20M | Buy |
+393,000
| New | +$20M | 0.36% | 83 |
|